The present invention relates to novel compounds of the Formula (I): 1 which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.

 
Web www.patentalert.com

< Method of applying thermodynamic therapy for the rejuvenation of a subject

< Eukaryotic genes involved in adult lifespan regulation

> Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents

> Bicyclic modulators of androgen receptor function

~ 00207